Jump Financial’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.17M | Buy |
322,846
+122,011
| +61% | +$1.95M | 0.06% | 396 |
|
|
2025
Q1 | $3.43M | Buy |
200,835
+71,167
| +55% | +$1.22M | 0.05% | 420 |
|
|
2024
Q4 | $3.21M | Buy |
129,668
+68,312
| +111% | +$1.69M | 0.07% | 370 |
|
|
2024
Q3 | $1.75M | Sell |
61,356
-90,116
| -59% | -$2.57M | 0.04% | 575 |
|
|
2024
Q2 | $4M | Buy |
151,472
+56,472
| +59% | +$1.49M | 0.08% | 305 |
|
|
2024
Q1 | $3.07M | Buy |
95,000
+65,928
| +227% | +$2.13M | 0.08% | 277 |
|
|
2023
Q4 | $1.22M | Buy |
29,072
+17,046
| +142% | +$718K | 0.04% | 601 |
|
|
2023
Q3 | $462K | Buy |
+12,026
| New | +$462K | 0.02% | 1065 |
|
|
2023
Q2 | – | Sell |
-45,600
| Closed | -$707K | – | 1969 |
|
|
2023
Q1 | $707K | Buy |
+45,600
| New | +$707K | 0.03% | 747 |
|
|
2022
Q2 | – | Sell |
-18,700
| Closed | -$103K | – | 1805 |
|
|
2022
Q1 | $103K | Sell |
18,700
-54,200
| -74% | -$299K | ﹤0.01% | 1404 |
|
|
2021
Q4 | $621K | Sell |
72,900
-700
| -1% | -$5.96K | 0.04% | 561 |
|
|
2021
Q3 | $640K | Sell |
73,600
-65,435
| -47% | -$569K | 0.05% | 416 |
|
|
2021
Q2 | $1.47M | Buy |
139,035
+116,471
| +516% | +$1.23M | 0.14% | 182 |
|
|
2021
Q1 | $361K | Buy |
22,564
+14,264
| +172% | +$228K | 0.03% | 531 |
|
|
2020
Q4 | $383K | Buy |
+8,300
| New | +$383K | 0.07% | 484 |
|